J84.170
Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere
Clinical Classification Guidelines
Inclusion Terms
- Progressive fibrotic interstitial lung disease
Code First
- underlying disease, such as:
- lung diseases due to external agents (J60-J70)
- rheumatoid arthritis (M05.00-M06.9)
- sarcoidosis (D86.-)
- systemic connective tissue disorders (M30-M36)
Medical Intelligence & Overview
Interstitial lung disease with a progressive fibrotic phenotype, classified under ICD-10 code J84.170, refers to a group of lung disorders characterized by scarring and fibrosis in the lungs that worsen over time. This condition involves abnormal inflammation and scarring of the lung tissue, which hampers breathing and reduces oxygen transfer into the bloodstream. As the fibrosis progresses, the lung tissue becomes less flexible, making it increasingly difficult to breathe deeply or perform physical activities. Recognizing the features of this disease is essential for understanding its impact and potential management options.
Causes & Symptoms
Clinical Causes: Certain autoimmune diseases such as rheumatoid arthritis or scleroderma Exposure to harmful substances like asbestos, silica, or coal dust Chronic environmental or occupational exposures Genetic predispositions in some cases Idiopathic instances where no specific cause can be identified Other underlying respiratory conditions that may contribute
Key Symptoms: Persistent dry cough Shortness of breath, especially during exertion Fatigue and general weakness Unintentional weight loss Clubbing of the fingers (enlargement of the fingertips) Chest discomfort or pain Gradual worsening of breathing difficulty
Diagnostic & Treatment
Diagnosis Path: Diagnosing this form of interstitial lung disease involves several steps:
Treatment Protocols: While there is no cure for progressive fibrotic interstitial lung disease, several strategies aim to manage symptoms and slow progression:
Clinical Advice & FAQs
Billing Guidance
Is J84.170 a billable ICD-10 code?
Yes, J84.170 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.170?
Clinical documentation must specify the nature of Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference